Ian Frew

Full Professor

University Medical Center Freiburg

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ian Frew is a Full Professor at Universitätsklinikum Freiburg, Germany. His research focuses on clear cell renal cell carcinoma, particularly the roles of various genetic and epigenetic factors, metabolic pathways, and their implications for tumor behavior and treatment. Recent publications include studies on annexin A4, KDM5 mutations, metabolomic analysis, and the therapeutic significance of mutations in bladder cancer.

Articles (9)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Yong Li

University Medical Center Freiburg

GERMANY

View details

Thomas Welte

GERMANY

View details

Niels Grabe

Professor for Data Analysis in Novel Clinical Diagnostics

Universitätsmedizin Göttingen

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ian Frew

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Versatile roles of annexin A4 in clear cell renal cell carcinoma: Impact on membrane repair, transcriptional signatures, and composition of the tumor microenvironment

KDM5C and KDM5D mutations have different consequences in clear cell renal cell carcinoma cells

Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma

SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC

Therapeutic significance of ARID1A mutation in bladder cancer

Therapeutic effects of inhibition of sphingosine-1-phosphate signaling in hif-2α inhibitor-resistant clear cell renal cell carcinoma

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition

HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice.

The complex genetics of epigenetics in urothelial carcinomas

Collaborators (3)

Yong Li

Thomas Welte

Niels Grabe

Make your next move.